GenHenn Venture

GenHenn Capital Venture Fund I LLC is a venture capital firm investing in early-stage life sciences, healthcare, and biotech companies developing high-impact solutions. We partner with visionary entrepreneurs, providing capital, strategic guidance, and deep industry expertise to help them navigate complex challenges and scale effectively. Founded in 2022 as a single-family office, we take a long-term approach, recognizing that breakthrough ideas require strong execution. Our $75 million fund focuses on Seed and Series A investments, typically deploying $2–$5 million per company. We actively support founders with top-tier leadership skills, prioritizing businesses with differentiated technology, a clear path to commercialization, and strong leadership. We structure our investments through equity, convertible securities, and other equity-linked instruments, with a core focus on medical devices, diagnostics, therapeutics, and healthcare infrastructure. As AI, data-driven research, and technological advancements accelerate industry breakthroughs, we seek companies positioned to capitalize on these shifts. To date, we have invested in 17 companies, measuring success not only in financial returns but in the lasting impact our portfolio companies have on industries, patients, and communities worldwide.